Where an average of 1,450 cases of respiratory syncytial virus (RSV) are reported each year in British Columbia, only five cases were reported in the province in 2020-2021 due largely to drastically reduced interactions while provincial lockdowns were in effect.
A CITF-funded study by researcher Dr. Kate Zinszer from the Université de Montréal and colleagues found that SARS-CoV-2 antibodies due to infection in children aged 2 to 17 years in Montreal increased over time, from 3.2% in October-November 2020 to 8.4% in March-April 2021.
In a letter published in Gut, Dr. Kevan Jacobson, Dr. Pascal Lavoie and collaborators from the University of British Columbia report modestly lower antibody levels in adolescents, aged 12 to 17 years, with inflammatory bowel disease (IBD) who are on the anti-TNF-a anti-inflammatory therapy infliximab in combination with other immunosuppressive drugs or given as monotherapy, after a first dose of Pfizer-BioNTech’s Comirnaty vaccine.
Drs. Pascal Lavoie and Louise Mâsse from the University of British Columbia and their team have released new findings from their CITF-funded study of SARS-CoV-2 transmission in Vancouver schools.
As part of their CITF-funded COVID-19 cohort study, Dr. Kate Zinszer and Dr. Caroline Quach from the Université de Montréal, along with colleagues, examined whether parents from certain socioeconomic backgrounds or racialized groups were more – or less – inclined to have their child or adolescent vaccinated.
CITF-funded researcher Dr. Kate Zinszer, from the Université de Montréal, and her EnCORE study team have released additional preliminary, non-peer reviewed results indicating a marked increase in the number of Montreal youth aged 2 to 17 with antibodies due to a SARS-CoV-2 infection in recent months.
Dr. Jonathon Maguire and Dr. Catherine Birken from the CITF-funded TARGet Kids! collaboration in Ontario investigated the association between public health preventive measures related to COVID-19 and health behaviours and activities in children 10 years of age and younger.
Dr. Kate Zinszer (Université de Montréal) and her EnCORE study team have released preliminary results based on data collected from an online questionnaire that parents filled out including updates on children’s behaviour and emotional health, as well as many parental concerns.
Preliminary results from a study underway in Montreal shed important light on the extent to which 2 to 17 years-old have had COVID-19 between last October 2020 and this April 2021. As an overall average, 5.8% of participating children were found to have antibodies to SARS-CoV-2, the virus that causes COVID-19.
Dr. Kate Zinszer, from the Université de Montréal, and her EnCORE study team have released interim non-peer reviewed results suggesting a marked increase in seroprevalence among Montreal children aged 2-17 years-old in recent months.